Insider Transactions in Q1 2023 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,370
-0.65%
|
$42,470
$31.14 P/Share
|
|
Mar 02
2023
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,298
-0.86%
|
$40,238
$31.14 P/Share
|
|
Mar 02
2023
|
Elaine Caughey Chief Business Officer |
SELL
Open market or private sale
|
Direct |
714
-1.82%
|
$22,134
$31.14 P/Share
|
|
Mar 01
2023
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,750
+18.31%
|
-
|
|
Mar 01
2023
|
Jared Gollob Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+19.79%
|
-
|
|
Mar 01
2023
|
Elaine Caughey Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,557
+34.89%
|
-
|
|
Jan 12
2023
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
18,897
+0.48%
|
$585,807
$31.24 P/Share
|
|
Jan 12
2023
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
21,592
-2.37%
|
$647,760
$30.29 P/Share
|
|
Jan 12
2023
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
77,128
-1.53%
|
$2,313,840
$30.29 P/Share
|
|
Jan 12
2023
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
98,720
-1.95%
|
$2,961,600
$30.29 P/Share
|
|
Jan 11
2023
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
22,110
+0.51%
|
$641,190
$29.89 P/Share
|
|
Jan 11
2023
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
6,071
-0.66%
|
$176,059
$29.96 P/Share
|
|
Jan 11
2023
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
21,683
-0.43%
|
$628,807
$29.96 P/Share
|
|
Jan 11
2023
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
27,754
-0.54%
|
$804,866
$29.96 P/Share
|
|
Jan 03
2023
|
Ellen Chiniara Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+50.0%
|
-
|